Jalaravi Kliinik OÜRegistered
Key figures
439 356 €−9,4%
Revenue 2025
+17,0%
Average annual growth 2019–2025
Ratios
2025−0,6%
Profit margin
2,2%
EBITDA margin
44,8%
Equity ratio
0,9×
Current ratio
−3,9%
Return on equity
1282 €
Average gross salary
Balance sheet structure
Current assetsNon-current assetsLiabilitiesEquity
Quarterly figures
| Quarter | Revenue | Number of employees | Labour taxes |
|---|---|---|---|
| Q2 2026 | 14 197 € | 13 | 24 508 € |
| Q1 2026 | 13 045 € | 13 | 23 081 € |
| Q4 2025 | 11 999 € | 11 | 25 490 € |
| Q3 2025 | 14 468 € | 12 | 27 830 € |
| Q2 2025 | 16 048 € | 12 | 28 443 € |
| Q1 2025 | 24 971 € | 13 | 28 989 € |
Source: Tax Board open data — based on VAT returns, may not exactly match revenue in the annual report. Updated quarterly.
Dividends
calculated2025
No dividends were distributed.
History
20250 €
20240 €
2023955 €
20220 €
20210 €
20200 €
Previous year's retained earnings + previous year's profit − current retained earnings.
Summary of financial statements2019–2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Balance sheet — assets | |||||||
| Total current assets | 12 417 | 29 388 | 17 652 | 24 690 | 33 795 | 40 259 | 43 994 |
| Total non-current assets | 16 862 | 14 574 | 107 517 | 157 302 | 141 088 | 119 328 | 107 868 |
| Total assets | 29 279 | 43 962 | 125 169 | 181 992 | 174 883 | 159 587 | 151 862 |
| Balance sheet — liabilities and equity | |||||||
| Current liabilities | 8013 | 9308 | 22 737 | 39 551 | 62 726 | 62 410 | 48 953 |
| Non-current liabilities | — | — | — | 34 205 | 37 760 | 26 560 | 34 948 |
| Total liabilities | 8013 | 9308 | 22 737 | 73 756 | 100 486 | 88 970 | 83 901 |
| Share capital | 2500 | 2500 | 2500 | 2500 | 2500 | 2500 | 2500 |
| Retained earnings of previous periods | 7918 | 18 766 | 32 154 | 99 932 | 104 781 | 71 897 | 68 117 |
| Profit for the year | 10 848 | 13 388 | 67 778 | 5804 | −32 884 | −3780 | −2656 |
| Total equity | 21 266 | 34 654 | 102 432 | 108 236 | 74 397 | 70 617 | 67 961 |
| Income statement | |||||||
| Sales revenue | 170 860 | 224 838 | 297 281 | 385 485 | 458 961 | 485 148 | 439 356 |
| Operating profit | 10 995 | 13 988 | 66 963 | 4413 | −29 706 | −4129 | −1636 |
| EBITDA | 13 283 | 16 276 | 69 251 | 9885 | −17 292 | 7331 | 9824 |
| Profit before income tax | 10 848 | 13 388 | 67 778 | 5804 | −32 884 | −3780 | −2656 |
| Profit for the reporting year | 10 848 | 13 388 | 67 778 | 5804 | −32 884 | −3780 | −2656 |
| Labour costs | 57 739 | 123 553 | 105 203 | 216 833 | 272 847 | 305 177 | 257 164 |
| Depreciation of non-current assets | 2288 | 2288 | 2288 | 5472 | 12 414 | 11 460 | 11 460 |
| Other indicators | |||||||
| Employees | 4 | 5 | 6 | 9 | 14 | 7 | 5 |
| Calculated dividend | — | 0 | 0 | 0 | 955 | 0 | 0 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
Click a node to see its other connections.
CompanyPersonShareholderOther roleAdditional link
Annual reportsPDF, XBRL
Loading list of reports…
Source: e-Business Register (RIK). Files open/download directly from the official register.
Related companies
Same activity — Õendusabi osutamine